In a patient admitted from the emergency department with chest pain, hemoglobin 7.2 g/dL (iron deficiency anemia), prolonged prothrombin time of 22.4 seconds, international normalized ratio of 2, partial thromboplastin time >200 seconds, not on anticoagulants, and a small right pleural effusion, what is the appropriate management?

Immediate Workup for Coagulopathy and Urgent Hematology Consultation

This patient requires immediate investigation for an acquired coagulopathy with urgent hematology consultation—the PTT >200 seconds is critically abnormal and demands immediate attention before any transfusion decisions are made.

Critical First Steps

The markedly prolonged PTT (>200 seconds) with moderately elevated PT/INR in a patient not on anticoagulants suggests either:

• Factor deficiency (acquired or congenital)
• Factor inhibitor (lupus anticoagulant or specific factor inhibitor)
• Preanalytical error (though less likely given the PT is also elevated)

Immediate Diagnostic Algorithm

Step 1: Repeat coagulation studies immediately 1

• Confirm the PTT >200 is not a preanalytical error (improper sample collection, excess citrate from hematocrit issues given the anemia) 2
• Order mixing study (1:1 mix of patient plasma with normal plasma):
  • If PTT corrects → factor deficiency
  • If PTT does not correct → inhibitor present 3

Step 2: Order specific tests based on mixing study 1

• If corrects: Check factor VIII, IX, XI, XII levels
• If doesn't correct: Check for lupus anticoagulant, specific factor inhibitors (especially factor VIII inhibitor)
• Check fibrinogen level (critical for bleeding risk assessment) 4

Step 3: Assess bleeding risk

• Examine for petechiae, ecchymoses, mucosal bleeding
• The small pleural effusion could represent hemothorax if coagulopathy is severe

Transfusion Management

Red Blood Cell Transfusion

Transfuse RBCs now for hemoglobin 7.2 g/dL in the setting of chest pain 5

• Target hemoglobin 7-9 g/dL in most critically ill patients 5
• However, with chest pain suggesting possible cardiac ischemia, a higher threshold is appropriate
• The restrictive transfusion strategy (Hgb <7 g/dL) does NOT apply when myocardial ischemia is present 5

Fresh Frozen Plasma - HOLD

Do NOT transfuse FFP empirically without understanding the underlying coagulopathy 5, 6

• FFP is indicated for active bleeding with coagulopathy, NOT for laboratory abnormalities alone 5
• This patient denies significant bleeding
• Wait for mixing study results to guide therapy 3
• If factor deficiency is confirmed and bleeding occurs, FFP 15 mL/kg is the starting dose 4

Platelet Transfusion - NOT Indicated

Platelet count is not mentioned as abnormal, so prophylactic platelet transfusion is not indicated 6

Management of Specific Scenarios

If Factor Inhibitor is Found:

• Lupus anticoagulant: Paradoxically causes thrombosis, not bleeding—no FFP needed unless actively bleeding 3
• Acquired factor VIII inhibitor: May require bypassing agents (recombinant factor VIIa or activated prothrombin complex concentrate) if bleeding occurs 3

If Factor Deficiency is Found:

• Congenital deficiency (hemophilia): Contact hemophilia center urgently for specific factor replacement 4
• Acquired deficiency: Treat underlying cause; FFP only if bleeding 5, 4

Iron Deficiency Anemia Management - Secondary Priority

Once the coagulopathy is addressed 7:

• Oral iron: Ferrous sulfate 324 mg daily (after acute issues resolved) 8, 7
• IV iron: Consider if oral not tolerated or malabsorption suspected (ferric gluconate 250 mg IV daily for 3 days) 8, 7
• Investigate source: GI evaluation for occult bleeding once coagulopathy is clarified 7, 9

Chest Pain Evaluation - Parallel Track

While addressing hematologic issues 10:

• Serial troponins and ECG monitoring
• Consider PE in differential (though anemia itself can cause chest pain) 11
• The pleural effusion requires characterization once coagulopathy is understood (thoracentesis contraindicated until coagulation normalized)

Critical Pitfalls to Avoid

1. Do not transfuse FFP for laboratory values alone in non-bleeding patients 5, 6
2. Do not assume the coagulopathy is dilutional or consumptive without mixing studies 1
3. Do not perform invasive procedures (thoracentesis, central lines) until coagulopathy is characterized 6
4. Do not delay hematology consultation—this degree of PTT prolongation requires specialist input 3, 1

Bottom line: Transfuse RBCs now, get mixing studies stat, consult hematology urgently, and hold FFP until the coagulopathy mechanism is understood.